Vladonix
Vladonix is an oral peptide bioregulator that the reference library lists for immune and thymus support. The proposed way it works, by acting on one specific tissue, is theoretical, and the library gives no studies for it.
At a glance
- Bioregulator
- oral
- Not yet audited here; the reference library calls it theoretical
- Sources differ. See the source
How much to draw
Full calculator →The reference does not report a single injectable amount for Vladonix, so the amount is yours to enter. The arithmetic is the same for any vial. How to reconstitute a vial.
What sources report
These are figures published elsewhere, reproduced with their source. Peppersite does not recommend an amount for Vladonix or for anything else, and nothing below has been checked against the study it came from.
| Amount | Frequency | Route | Reported by |
|---|---|---|---|
| 1-2 capsules daily (commonly 2 capsules daily) | once or twice daily20-30 day course · Repeat course 1-2x per year | oral | Commonly published practitioner dosing range - provider confirmation required. |
- once or twice daily20-30 day course · Repeat course 1-2x per year
- oral
- Commonly published practitioner dosing range - provider confirmation required.
- Oral capsules (peptide bioregulator) · Not applicable (oral capsule)
We have not published an audit on Vladonix. Everything below is reference material, not our own reading of the literature, treat it as a starting point for questions, not as a grade.
How it is thought to work
Tissue-specific peptide bioregulation (theoretical).
The reference sections on this page come from a compound library we import, not from our own review of the studies. Our own evidence grade appears only where an audit is linked. Research use only; nothing here is medical advice or a protocol.
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small lab-made molecule, not a true peptide, though it is often sold alongside research peptides. It is studied for shrinking fat cells and raising NAD+ levels, and all evidence so far comes from cell and rodent studies, with no published human trial.
BPC-157 (Body Protection Compound 157) is a lab-made chain of 15 amino acids based on a sequence first found in human gastric juice. It is mostly studied in animal models of tendon, ligament, gut and blood-vessel injury, and human evidence is limited to three small pilots.
Cerluten is an oral peptide bioregulator referenced for nervous system support. Its proposed action, tissue-specific peptide bioregulation, is described as theoretical.
CJC-1295 with DAC is a lab-made 30-amino-acid copy of growth hormone-releasing hormone, altered so it attaches to albumin, a protein in the blood. It was studied in early human trials for its effect on growth hormone and IGF-1 levels.
This is a combination research blend sold as one vial: CJC-1295 without DAC, a copy of growth hormone-releasing hormone, plus Ipamorelin, a short peptide that acts on the ghrelin receptor. It is studied as a GHRH and GHRP pairing in growth-hormone research.
Endoluten is a peptide bioregulator taken by mouth, listed in the reference library as pineal support. Its proposed action, tissue-specific peptide bioregulation, is described as theoretical.